A ‘vaccine’ which could battle many forms of terminal cancer is to be tested in the UK.
The immunotherapy trial will examine whether a vaccine, based on
fragments of a key cancer protein, is effective in stimulating the
body’s own immune system to destroy unhealthy cells.
‘This is pushing new boundaries for potential cancer treatments,’ said life sciences minister George Freeman.
Scientists, led by Surrey Cancer Research Institute, are recruiting patients who have failed to respond to treatment.
Two patients have already received the vaccine as part of the trial, which is expected to run for up to two years.
Immunotherapy is generating great interest in the cancer research community.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment